Waseda to strip Obokata of doctorate unless dissertation corrected

Waseda to strip Obokata of doctorate unless dissertation corrected

TOKYO, Japan - Photo shows Haruko Obokata, a 31-year-old researcher at the Japanese government-affiliated Riken institute. Waseda University said Oct. 7, 2014, it will strip Obokata of her doctorate unless she corrects her dissertation, following her involvement in a scandal earlier in the year related to research on so-called STAP cells. Citing a serious fault in the dissertation screening process, the university gave Obokata a year to correct a number of irregularities including the use of material from a U.S. website. (Kyodo)

  • Product Code
  • ILEA000337041
  • Registered date
  • 2014/10/07 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 567 × 803 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 93.55(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

    (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts equipment at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In
      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

      (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (L) talks with a researcher at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular s
        Renowned researcher leaves Riken institute

        Renowned researcher leaves Riken institute

        Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute who led a team that succeeded for the first time in the world in transplanting into a woman retinal cells grown from her own iPS cells in 2014. Riken announced on July 31, 2019, that Takahashi will leave the institute the same day. (Kyodo) ==Kyodo
          Retina transplants via donor iPS cells

          Retina transplants via donor iPS cells

          Masayo Takahashi, a researcher at the Japanese government-backed Riken institute, speaks at an academic conference in Tokyo on April 18, 2019. Five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors, she said. (Kyodo) ==Kyodo
            Retina transplants via donor iPS cells

            Retina transplants via donor iPS cells

            Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute. She said in Tokyo on April 18, 2019 that five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors. (Kyodo) ==Kyodo
              Purported "STAP cells" likely came from embryonic stem cells

              Purported "STAP cells" likely came from embryonic stem cells

              TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21.
                Purported "STAP cells" likely came from embryonic stem cells

                Purported "STAP cells" likely came from embryonic stem cells

                TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21. (Kyodo)
                  Waseda to strip Obokata of doctorate unless dissertation corrected

                  Waseda to strip Obokata of doctorate unless dissertation corrected

                  OSAKA, Japan - Hideo Miki, a lawyer for Haruko Obokata, a 31-year-old researcher at the Japanese government-affiliated Riken institute, meets the press in the city of Osaka on Oct. 7, 2014, after Waseda University said it will strip Obokata of her doctorate unless she corrects her dissertation. (Kyodo)
                    Waseda to strip Obokata of doctorate unless dissertation corrected

                    Waseda to strip Obokata of doctorate unless dissertation corrected

                    TOKYO, Japan - Photo shows Haruko Obokata, a 31-year-old researcher at the Japanese government-affiliated Riken institute. Waseda University said Oct. 7, 2014, it will strip Obokata of her doctorate unless she corrects her dissertation, following her involvement in a scandal earlier in the year related to research on so-called STAP cells. Citing a serious fault in the dissertation screening process, the university gave Obokata a year to correct a number of irregularities including the use of material from a U.S. website.
                      Riken team has not reproduced STAP cells

                      Riken team has not reproduced STAP cells

                      TOKYO, Japan - Hitoshi Niwa, a researcher at the Riken research institute who heads the team reexamining the so-called STAP cells, speaks at a news conference in Tokyo on Aug. 27, 2014. He said the team has yet to reproduce through ongoing experiments the cells described in Haruko Obokata's research papers, which she subsequently withdrew amid allegations of misconduct. (Kyodo)